Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Blood Pressure Changes Impact Corticospinal Connectivity and Downstream Gait and Balance Control
Cerebrovascular Disease and Interventional Neurology
P12 - Poster Session 12 (5:30 PM-6:30 PM)
13-010

BP plays an important role in cerebrovascular health and WM integrity with sex specific mechanisms influencing WM pathology. The role of intra-individual BP variability as a contributor to WM dysfunction is unclear, particularly involving motor control regions.

To determine the role of intra-individual blood pressure (BP) change as a contributor to white matter (WM) damage on MRI and to evaluate the impact of these changes on gait speed and imbalance by sex.

We identified 990 participants enrolled in the population-based Mayo Clinic Study of Aging who had at least 2 BP measurements prior to baseline MRI. The Rochester Epidemiology Project was used to capture vascular risk factors and imbalance. We analyzed fractional anisotropy (FA) and mean diffusivity in WM regions associated with motor control. We evaluated the effect of BP changes and identified regions impacted by BP.  Using structural equation models (SEM), we assessed the effect of BP slope on corticospinal tract (CST) FA, and downstream effects on gait speed and imbalance after age and sex effects.

Of 990 participants, 438 (44%) were women. Hypertension was similar between women and men (67% and 70%; = 0.301).  There was no difference in systolic BP slope and variability between sexes (=0.411 and p = 0.424).  Gait speed and imbalance were similar between sexes (= 0.506; = 0.453).   In linear models predicting CST FA, the only WM region associated with BP slope, a greater change in BP slope (0.0004; = 0.026) and female sex (0.017; p<0.001) were significant predictors of lower CST FA.  SEMs showed that older age, female sex, and higher BP slope predicted lower CST FA, and lower CST FA predicted lower gait speed and higher odds of imbalance. 

Intra-individual BP slope and variability impact corticospinal tract connectivity with women having increased susceptibility to damage. 

Authors/Disclosures
Elizabeth A. Coon, MD, FAAN (Mayo Clinic)
PRESENTER
Dr. Coon has nothing to disclose.
Anna Castillo No disclosure on file
Timothy Lesnick No disclosure on file
Michelle M. Mielke, PhD (Wake Forest University School of Medicine) Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Robert I. Reid No disclosure on file
No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN (Mayo Clinic) Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Prashanthi Vemuri, PhD (Mayo Clinic) The institution of Dr. Vemuri has received research support from NIH.